Skip to main content
. Author manuscript; available in PMC: 2023 May 1.
Published in final edited form as: Lancet Haematol. 2022 Mar 25;9(5):e340–e349. doi: 10.1016/S2352-3026(22)00069-2

Figure 3. Association of monoclonal gammopathies with all-cause mortality.

Figure 3.

Figure 3.

(A) Multivariable Cox proportional-hazards model for any monoclonal gammopathy detected in all screened participants from the MGBB on overall survival adjusted for age, gender, risk group, and Charlson Comorbidiy Index. (B) Multivariable Cox proportional-hazards model for any monoclonal gammopathy detected in screened participants age ≥50, on overall survival, adjusted for age, gender, risk group, and Charlson Comorbidiy Index. CI: Confidence interval, HR: Hazard ratio, MS: Mass spectrometry.